Keywords: Merck KGaA, Eprova, Isofol, Modufolin, Cancer, Licensig

Merck KgaA unit and Isofol in deal for Modufolin in oncology

Article | 12 November 2009

Print This

Switzerland-based Merck Eprova, part of Germand drug major Merck KgaA, has signed an exclusive license agreement with Isofol Medical AB ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in